Quarterly report pursuant to Section 13 or 15(d)

Supplemental Cash Flow Information Disclosure: Schedule of Cash Flow, Supplemental Disclosures (Details)

v2.4.0.8
Supplemental Cash Flow Information Disclosure: Schedule of Cash Flow, Supplemental Disclosures (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2014
Sep. 30, 2013
Details      
Cash paid for interest   $ 229,571 $ 95,042
Cash paid for income taxes     100
Series C Dividend payable in accounts payable     27,068
Series D Dividend payable in accrued expenses   53,054 24,407
Repayment of senior secured notes payable with Series D preferred shares     749,982
Financing the purchase of equipment under a 5 year loan agreement   49,204 83,507
Beneficial conversion feature on warrants issued in conjunction with Series D preferred shares   24,279  
Shares issued in acquisition of Dr. Pave   175,000  
Deemed dividend related to warrant extension $ 26,832 $ 26,832